The Clinical Management of Chondrosarcoma
- 677 Downloads
Chondrosarcomas (CHS) represent a heterogeneous group of disorders ranging from indolent, low-grade tumors to aggressive, high-grade forms. Surgical resection represents the primary and preferred treatment modality for individuals with localized disease. Radiation therapy is appropriate for the treatment of positive surgical margins or palliation of disease-related symptoms. The treatment of advanced, metastatic disease is particularly challenging given the recognition that conventional chemotherapy has proven to be largely ineffective. Systemic chemotherapy may be considered in variant forms such as mesenchymal or dedifferentiated chondrosarcomas but high-quality data supporting its use is limited. There is universal agreement, however, that novel treatment strategies are desperately needed. This review will highlight the need for a coordinated multidisciplinary approach to optimize the management and care of patients.
KeywordsStandard Uptake Value National Comprehensive Cancer Network Radiat Oncol Biol Phys Chondrosarcoma National Comprehensive Cancer Network
Cobalt gray equivalent
Disease free survival
Fractionated stereotactic radiation therapy
Magnetic resonance imaging
National comprehensive cancer network
Positron emission tomography
Standard uptake value
TNF-related apoptosis inducing ligand
Unable to display preview. Download preview PDF.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance • Of major importance
- 1.•Damron TA, Ward WG, Stewart A: Osteosarcoma, chondrosarcoma, and Ewing’s sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res 2007, 459:40–7. doi: 10.1097/BLO.0b013e318059b8c9.
A descriptive summary of epidemiological and survival data for the single largest series of cases for each of the three most common sarcomas of bone.
- 9.Nakashima Y, Park YK, Sugano O: Mesenchymal chondrosarcoma. In World Health Organization Classification of Tumours: Pathology and Genetics. Tumours of Soft Tissue and Bone. Edited by Fletcher CDM, Unni KK, Mertens F. Lyon, France: IARC Press; 2002: 255–256.Google Scholar
- 35.Delaney TF, Liebsch NJ, Pedlow FX, et al.: Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 2008 (Epub ahead of print).Google Scholar
- 37.••Biermann JS, Adkins D, Benjamin R, et al.: Bone cancer. J Natl Compr Canc Netw 2007, 5(4):420–437.Google Scholar
NCCN consensus guidelines for the management of patients with bone cancers, including chondrosarcomas.
- 39.Available at http://www.clinicaltrials.gov/ct2/results?term=chondrosarcoma. Accessed January 2, 2009.